Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,687 | -37,926 | -20,032 | -24,597 | -68,876 |
| Depreciation Amortization | 1,309 | 888 | 540 | 221 | 734 |
| Accounts receivable | -2,690 | -100 | -1,241 | -1,118 | -2,224 |
| Accounts payable and accrued liabilities | -219 | 1,148 | -289 | 151 | -57 |
| Other Working Capital | -48,194 | -10,318 | -15,317 | -6,943 | 85,002 |
| Other Operating Activity | 15,099 | 17,386 | 18,163 | 20,153 | 20,302 |
| Operating Cash Flow | $-60,382 | $-28,922 | $-18,176 | $-12,133 | $34,881 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,055 | -26,055 | -24,417 | -22,420 | N/A |
| PPE Investments | -1,085 | -807 | -643 | -25 | -741 |
| Investing Cash Flow | $-17,140 | $-26,862 | $-25,060 | $-22,445 | $-741 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 24,736 |
| Debt Repayment | N/A | N/A | N/A | N/A | -19,313 |
| Common Stock Issued | 52,897 | 31,741 | 30,291 | 21,307 | 3,464 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 5,544 |
| Financing Cash Flow | $52,897 | $31,741 | $30,291 | $21,307 | $14,431 |
| Exchange Rate Effect | -3 | 3 | 9 | -7 | -58 |
| Beginning Cash Position | 140,064 | 140,064 | 140,064 | 140,064 | 91,551 |
| End Cash Position | 115,436 | 116,024 | 127,128 | 126,786 | 140,064 |
| Net Cash Flow | $-24,628 | $-24,040 | $-12,936 | $-13,278 | $48,513 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,382 | -28,922 | -18,176 | -12,133 | 34,881 |
| Capital Expenditure | -1,085 | -807 | -643 | -25 | -815 |
| Free Cash Flow | -61,467 | -29,729 | -18,819 | -12,158 | 34,066 |